Systematic Reviews
Copyright ©The Author(s) 2019.
World J Clin Cases. Aug 26, 2019; 7(16): 2269-2286
Published online Aug 26, 2019. doi: 10.12998/wjcc.v7.i16.2269
Table 7 LI-RADS 2018 recommendations for untreated ≥ 1 cm lesions without pathologic proof in patients at high risk for HCC
LR-NCCannot be categorized (image degradation, lack of key phases)
LR-1Definitely benign (e.g., cyst, hemangioma, perfusion alteration)
LR-2Probably benign (probable but no definitive LR-1 findings)
LR-3Intermediate probability of malignancy (nonmalignant and malignant entities each have moderate probability)
LR-4High probability but no certainty of HCC
LR-5Definitively HCC
LR-MProbably or definitely malignant, not HCC specific (e.g., HCC not meeting LR-5 criteria, intrahepatic cholangiocarcinoma, metastases to liver)
LR-TIVTumor in vein